Dataset Information


Radiofrequency Catheter Ablation Improves the Quality of Life Measured with a Short Form-36 Questionnaire in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.

ABSTRACT: BACKGROUND:The main purpose of performing radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients is to improve the quality of life (QoL) and alleviate AF-related symptoms. We aimed to determine the qualitative and quantitative effects of RFCA on the QoL in AF patients. METHODS:We performed a systemic review and meta-analysis using a random effects model. We searched for the studies that reported the physical component summary score (PCS) and mental component summary score (MCS) of the short form-36, a validated system to assess and quantify the QoL, before and after RFCA in AF patients. PCS and MCS are T-scores with a mean of 50 and standard deviation of 10. RESULTS:Of the 470 studies identified through systematic search, we included 13 studies for pre-RFCA vs. the post-RFCA analysis and 5 studies for treatment success vs. AF recurrence analyses. In the pre-RFCA vs. post-RFCA analysis, RFCA was associated with a significant increase in both the PCS (weighted mean difference [WMD] = 6.33 [4.81-7.84]; p < 0.001) and MCS (WMD = 7.80 [6.15-9.44]; p < 0.001). The ?PCS (post-RFCA PCS-pre-RFCA PCS) and ?MCS values were used for the treatment success vs. AF recurrence analysis. Patients with successful ablation had a higher ?PCS (WMD = 7.46 [4.44-10.49]; p < 0.001) and ?MCS (WMD = 7.59 [4.94-10.24]; p < 0.001). CONCLUSIONS:RFCA is associated with a significant increase in the PCS and MCS in AF patients. Patients without AF recurrence after RFCA had a better improvement in the PCS and MCS than patients who had AF recurrence.


PROVIDER: S-EPMC5040266 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6504925 | BioStudies
2017-01-01 | S-EPMC5445294 | BioStudies
2018-01-01 | S-EPMC6177159 | BioStudies
2019-01-01 | S-EPMC6499800 | BioStudies
2018-01-01 | S-EPMC7504973 | BioStudies
2019-01-01 | S-EPMC6402671 | BioStudies
2018-01-01 | S-EPMC6045646 | BioStudies
2019-01-01 | S-EPMC6925461 | BioStudies
2015-01-01 | S-EPMC4508979 | BioStudies
2018-01-01 | S-EPMC5783382 | BioStudies